Although normal ER-positive cells do not proliferate and estrogen-ER signaling induces the proliferation of ER-negative cells via a paracrine mechanism [44], [58], estrogen-ER signaling is clearly mitogenic and promotes cell proliferation in ER-positive breast cancer cells. Here, ESR1 is linked to breast carcinoma.